Publications by authors named "Ramon Devesa"
Article Synopsis
- The study examines the effectiveness and safety of ultrafiltration (UF) compared to traditional diuretic therapy in treating cardiac decompensation associated with cardiorenal syndrome (CRS), especially when diuretics yield poor results.
- Analyzed data from 13 studies involving around 1,100 patients showed that UF had better trends in reducing creatinine and facilitating greater weight loss and fluid removal compared to diuretics, without impacting mortality or hospital stay durations significantly.
- The findings suggest that UF could be a beneficial alternative for patients not responding well to diuretics, potentially lowering readmission rates, though further prospective studies are necessary to confirm these benefits.
Background: Heart failure is frequently associated with kidney disease, and patients with kidney disease are at increased risk of heart failure. The co-occurrence of both entities not only significantly increases morbidity and mortality but also complicates therapy.
Summary: Cardiorenal syndrome often requires a broad, comprehensive, and multidisciplinary approach.
Background: After application of K/DOQI recommendations, a large proportion of our patients failed to reach the proposed targets. This study examined the causes of these findings.
Methods: Patients (n=163) were compared in 2 periods (8 months before and after application of K/DOQI guidelines).
Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
Nephrol Dial Transplant
June 2007
Background: The purpose of the present study was to evaluate the impact of cinacalcet administration on the attainment of Kidney Disease Outcomes Quality Initiative of the National Kidney Foundation (NFK-K/DOQI) targets, in a group of dialysis patients with secondary hyperparathyroidism that were not controlled with vitamin D metabolites due to inadequate elevations in serum calcium and/or phosphorus.
Methods: Twenty-eight patients undergoing haemodialysis that presented secondary hyperparathyroidism (PTH > 300 pg/ml) with difficulty to use vitamin D either because of hypercalcaemia (>10.2 mg/dl) and/or hyperphosphoraemia (>5.